Korro Bio
KRRO
64 hedge funds and large institutions have $286M invested in Korro Bio in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 11 closing their positions.
154% more capital inflows, than outflows
Capital inflows: $124M | Capital outflows: $49M
136% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 11
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
31% more funds holding
Funds holding: 49 → 64 (+15)
4.84% more ownership
Funds ownership: 86.16% → 91% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deep Track Capital
Greenwich,
Connecticut
|
+$42.6M |
| 2 |
BlackRock
New York
|
+$18M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.5M |
| 5 |
Driehaus Capital Management
Chicago,
Illinois
|
+$6.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$14.6M |
| 2 |
Suvretta Capital Management
New York
|
-$6.64M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$6.52M |
| 4 |
Monashee Investment Management
Boston,
Massachusetts
|
-$4.98M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.87M |
KRRO Hedge Fund Activity: Q2 2024 in Review
64 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2024, worth a combined $286M — down 54% from $619M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new KRRO positions and 11 closed out — a net gain of 15 holders — while 17 added to existing stakes and 12 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $42.6M. The largest seller was Cormorant Asset Management, cutting an estimated $14.6M.
- 64 institutional investors held Korro Bio (KRRO) as of Q2 2024, up from 49 in Q1 2024.
- Funds reported $286M of Korro Bio stock for Q2 2024, down 54% quarter-over-quarter.
- 26 funds opened new Korro Bio positions in Q2 2024 and 11 closed out, a net change of +15 holders.
- The largest Korro Bio buyer in Q2 2024 was Deep Track Capital, an estimated $42.6M added.
- The largest Korro Bio seller in Q2 2024 was Cormorant Asset Management, an estimated $14.6M sold.
Based on aggregated 13F filings for Q2 2024.